Pharmacological analysis of zebrafish (Danio rerio) scototaxis

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 35, Issue 2, 2011, Pages 624-631

  Maximino, Caio ^a,b   da Silva, Annanda Waneza Batista ^a   Gouveia, Amauri ^a   Herculano, Anderson Manoel ^a,b  

^a FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^b Zebrafish Neuroscience Research Consortium   (Brazil)

Author keywords

Anxiety; Light dark preference; Zebrafish

Indexed keywords

ALCOHOL; ANXIOLYTIC AGENT; BENZODIAZEPINE; BUSPIRONE; CAFFEINE; CHLORDIAZEPOXIDE; CLONAZEPAM; DIAZEPAM; DIZOCILPINE; FLUOXETINE; MOCLOBEMIDE;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; DRUG MEGADOSE; EXPERIMENTAL TEST; HORMESIS; LOCOMOTION; NONHUMAN; PARAMETRIC TEST; PHENOTYPE; PHYSICAL ACTIVITY; SCOTOTAXIS TEST; TRANQUILIZING ACTIVITY; ZEBRA FISH;

ADAPTATION, OCULAR; ANIMALS; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANXIETY; BEHAVIOR, ANIMAL; BENZODIAZEPINES; CAFFEINE; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CENTRAL NERVOUS SYSTEM STIMULANTS; DARK ADAPTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; MOTOR ACTIVITY; ZEBRAFISH;

EID: 79952855266     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2011.01.006     Document Type: Article

References (50)

1. Andersen M.L., D'Almeida V., Ko G.M., Kawakami R., Martins P.J.F., Magalhães L.E., et al. Princípios éticos e práticos do uso de animais de experimentação 2008, Universidade Federal Paulista/ SBCAL, São Paulo.
2. Anichtchik O.V., Sallinen V., Peitsaro N., Panula P. Distinct structure and activity of monoamine oxidase in the brain of zebrafish (Danio rerio). J Comp Neurol 2006, 498:593-610.
3. ASAB/ABS Guidelines for the treatment of animals in behavioural research and teaching. Anim Behav 2006, 71:245-253.
4. Bencan Z., Sledge D., Levin E.D. Buspirone, chlordiazepoxide and diazepam effects in a zebrafish model of anxiety. Pharmacol Biochem Behav 2009, 94:75-80.
5. Beulig A., Fowler J. Fish on Prozac: effect of serotonin reuptake inhibitors on cognition in goldfish. Behav Neurosci 2008, 122:426-432.
6. Blaser R.E., Chadwick L., McGinnis G.C. Behavioral measures of anxiety in zebrafish (Danio rerio). Behav Brain Res 2010, 208:56-62.
7. Bourin M., Hascöet M. The mouse light/dark box test. Eur J Pharmacol 2003, 463:55-65.
8. Bourin M., Hascöett M. The mouse light/dark box test. Eur J Pharmacol 2003, 463:55-65.
9. Burghardt N.S., Bush D.E.A., McEwen B.S., LeDoux J.E. Acute selective serotonin reuptake inhibitors increase conditioned fear expression: blockade with a 5-HT2C receptor antagonist. Biol Psychiatry 2007, 62:1111-1118.
10. Cachat J., Stewart A., Grossman L., Gaikwad S., Kadri F., Chung K.M., et al. Measuring behavioral and endocrine responses to novelty stress in adult zebrafish. Nat Protoc 2010, 5:1786-1799.
11. Calabrese E.J. An assessment of anxiolytic drug screening tests: hormetic dose response predominate. Crit Rev Toxicol 2008, 38:489-542.
12. Chaouloff F., Durand M., Mormede P. Anxiety- and activity-related effects of diazepam and chlordiazepoxide in the rat light/dark and dark/light tests. Behav Brain Res 1997, 85:27-35.
13. Clements S., Schreck C.B. Chronic administration of fluoxetine alters locomotor behavior, but does not potentiate the locomotor stimulating effects of CRH in juvenile Chinook salmon (Oncorhynchus tshawytscha). Comp Biochem Physiol A 2007, 147:43-49.
14. Daly J.W., Shi D., Nikodijević O., Jacobson K.A. The role of adenosine receptors in the central action of caffeine. Caffeine and behavior: current views and research trends 1999, CRC Press, Boca Raton. B.S. Gupta, U. Gupta (Eds.).
15. Drapier D., Bentué-Ferrer D., Laviolle B., Millet B., Allain H., Bourin M., et al. Effects of acute fluoxetine, paroxetine and desipramine on rats tested on the elevated plus-maze. Behav Brain Res 2007, 176:202-209.
16. Egan R.J., Bergner C.L., Hart P.C., Cachat J.M., Canavello P.R., Elegante M.F., et al. Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafish. Behav Brain Res 2009, 205:38-44.
17. Gerlai R. High-throughput behavioral screens: the first step towards finding genes involved in vertebrate brain function using zebrafish. Molecules 2010, 15:2609-2622.
18. Gerlai R., Lahav M., Guo S., Rosenthal A. Drinks like a fish: zebrafish (Danio rerio) as a behavior genetic model to study alcohol effects. Pharmacol Biochem Behav 2000, 67:773-782.
19. Griebel G., Sanger D.J., Perrault G. Further evidence for differences between non-selective and BZ-1 (omega 1) selective, benzodiazepine receptor ligands in murine models of "state" and "trait" anxiety. Neuropharmacology 1996, 35:1081-1091.
20. Grossman L., Utterback E., Stewart A., Gaikwad S., Chung K.M., Suciu C., et al. Characterization of behavioral and endocrine effects of LSD on zebrafish. Behav Brain Res 2010, 214:277-284.
21. Hascoet M., Bourin M. A new approach to the light/dark test procedure in mice. Pharmacol Biochem Behav 1998, 60:645-653.
22. Jain N., Kemp N., Adeyemo O., Buchanan P., Stone T.W. Anxiolytic activity of adenosine receptor activation in mice. Br J Pharmacol 1995, 116:2127-2133.
23. Key B., Devine C.A. Zebrafish as an experimental model: strategies for developmental and molecular neurobiology studies. Meth Cell Sci 2003, 25:1-6.
24. Krystal J.H., Tabakoff B. Ethanol abuse, dependence, and withdrawal: neurobiology and clinical implications. Neuropsychopharmacology: the fifth generation of progress 2002, Raven Press/ American College of Neuropsychopharmacology, New York. K.L. Davis, D. Charney, J.T. Coyle, C. Nemeroff (Eds.).
25. Lau B., Gould G.G., Guo S. Bright light activates a zebrafish innate avoidance circuitry encompassing Dm, the teleostean homologue of pallial amygdala 2010.
26. Lieberman J.A., Tasman A. Handbook of psychiatric drugs 2006, John Wiley & Sons Ltd, Chichester.
27. López-Patiño M.A., Yu L., Cabral H., Zhdanova I.V. Anxiogenic effects of cocaine withdrawal in zebrafish. Physiol Behav 2008, 93:160-171.
28. Maximino C., Brito T.M., Batista A.W.S., Herculano A.M., Morato S., Gouveia A. Measuring anxiety in zebrafish: a critical review. Behav Brain Res 2010, 214:157-171.
29. Maximino C., Brito T.M., Colmanetti R., Pontes A.A.A., Castro H.M., Lacerda R.I.T., et al. Parametric analyses of anxiety in zebrafish scototaxis. Behav Brain Res 2010, 210:1-7.
30. Maximino C., Brito T.M., Dias C.A.G.d.M., Gouveia A., Morato S. Scototaxis as anxiety-like behavior in fish. Nature Protocols 2010, 5:221-228.
31. Maximino C., Herculano A.M. A review of monoaminergic neuropsychopharmacology in zebrafish. Zebrafish 2010, 7:359-378.
32. Meller E., Goldstein M., Bohmaker K. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists. Mol Pharmacol 1990, 37:231-237.
33. Misslin R., Cigrang M. Does neophobia necessarily imply fear or anxiety?. Behav Process 1986, 12:45-50.
34. Norton W.H.J., Folchert A., Bally-Cuif L. Comparative analysis of serotonin receptor (HTR1A/HTR1B families) and transporter (slc6a4a/b) gene expression in the zebrafish brain. J Comp Neurol 2008, 511:521-542.
35. Panula P., Chen Y.-C., Priyadarshini M., Kudo S., Semenova S., Sundvik M., et al. The comparative neuroanatomy and neurochemistry of zebrafish CNS systems of relevante to human neuropsychiatric diseases. Neurobiol Disease. 2010, 40:46-57.
36. Peng J., Wagle M., Mueller T., Mathur P., Lockwood B.L., Bretaud S., et al. Ethanol-modulated camouflage response screen in zebrafish uncovers a novel role for cAMP and ERK signaling in behavioral sensitivity to ethanol. J Neurosci 2009, 29:8408-8418.
37. Sackerman J., Donegan J.J., Cunningham C.S., Nguyen N.N., Lawless K., Long A., et al. Zebrafish behavior in novel environments: effects of acute exposure to anxiolytic compounds and choice of Danio rerio line. Int J Comp Psychology 2010, 23:43-61.
38. Sallinen V., Sundvik M., Reenilä I., Peitsaro N., Khrustalyov D., Anichtchik O.V., et al. Hyperserotonergic phenotype after monoamine oxidase inhibition in larval zebrafish. J Neurochem 2009, 109:403-415.
39. Setini A., Pierucci F., Senatori O., Nicotra A. Molecular characterization of monoamine oxidase in zebrafish (Danio rerio). Comp Biochem Physiol B Biochem Mol Biol 2005, 140:153-161.
40. Severinsen K., Sinning S., Müller H.K., Wiborg O. Characterization of the zebrafish serotonin transporter functionally links TM10 to the ligand binding site. J Neurochem 2008, 105:1794-1805.
41. Shimada T., Matsumoto K., Osanai M., Matsuda H., Terasawa K., Watanabe H. The modified light/dark transition test in mice: evaluation of classic and putative anxiolytic and anxiogenic drugs. Gen Pharmacol 1995, 26:205-210.
42. Silva R.C., Brandão M.L. Acute and chronic effects of gepirone and fluoxetine in rats tested in the elevated plus-maze: An ethological analysis. Pharmacol Biochem Behav 2000, 65:209-216.
43. Stewart A., Kadri F., DiLeo J., Chung K.M., Cachat J., Goodspeed J., et al. The developing utility of zebrafish in modeling neurobehavioral disorders. Intl J Comp Psychol 2010, 23:104-120.
44. Stewart A, Maximino C, Brito TM, Herculano AM, Gouveia A, Jr., Morato S, et al. Neurophenotyping of adult zebrafish using the light/dark box paradigm. In: Kalueff AV, Cachat J, editors. Zebrafish neurobehavioral protocols. New York: Humana Press; 2010b. p. In press.
45. Stewart A, Wu N, Cachat J, Hart P, Gaikwad S, Wong K, et al. Pharmacological modulation of anxiety-like phenotypes in adult zebrafish behavioral models. Progress in Neuro-Psychopharmacology and Biological Psychiatry. In press.
46. Wang Y., Takai R., Yoshioka H., Shirabe K. Characterization and expression of serotonin transporter genes in zebrafish. Tohoku J Exp Med 2006, 208:267-274.
47. Westerfield M. The zebrafish book. A guide for the laboratory use of zebrafish Danio (Brachydanio) rerio 2000, University of Oregon Press, Eugene. 4th ed.
48. Wong K., Elegante M.F., Bartels B.K., Elkhayat S.I., Tien D.H., Roy S., et al. Analyzing habituation responses to novelty in zebrafish (Danio rerio). Behav Brain Res 2010, 208:450-457.
49. Woodnorth M.A., McNaughton N. Similar effects of medial supramammilary or systemic injections of chlordiazepoxide on both theta frequency and fixed-interval responding. Cogn Affect Behav Neurosci 2002, 2:76-83.
50. Zangrossi H., File S.E. Chlordiazepoxide reduces the generalised anxiety, but not the direct responses, of rats exposed to cat odor. Pharmacol Biochem Behav 1992, 43:1195-1200.